Evidence map›Paper›PMID 39006023›Full record

ReviewPeerJ2024

Hypertension in frail older adults: current perspectives.

Liying Li, Linjia Duan, Ying Xu, Haiyan Ruan, Muxin Zhang, Yi Zheng, Sen He

Abstract readReview
In one paragraph

Review in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liying Li *Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Linjia Duan *Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Ying XuDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Haiyan RuanDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Muxin ZhangDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Yi ZhengDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Sen HeDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu, China.

Funding

National Natural Science Foundation of ChinaSichuan Science and Technology Program, China
6 · The paper itself

Abstract

Hypertension is one of the most common chronic diseases in older people, and the prevalence is on the rise as the global population ages. Hypertension is closely associated with many adverse health outcomes, including cardiovascular disease, chronic kidney disease and mortality, which poses a substantial threat to global public health. Reasonable blood pressure (BP) management is very important for reducing the occurrence of adverse events. Frailty is an age-related geriatric syndrome, characterized by decreased physiological reserves of multiple organs and systems and increased sensitivity to stressors, which increases the risk of falls, hospitalization, fractures, and mortality in older people. With the aging of the global population and the important impact of frailty on clinical practice, frailty has attracted increasing attention in recent years. In older people, frailty and hypertension often coexist. Frailty has a negative impact on BP management and the prognosis of older hypertensive patients, while hypertension may increase the risk of frailty in older people. However, the causal relationship between frailty and hypertension remains unclear, and there is a paucity of research regarding the efficacious management of hypertension in frail elderly patients. The management of hypertension in frail elderly patients still faces significant challenges. The benefits of treatment, the optimal BP target, and the choice of antihypertensive drugs for older hypertensive patients with frailty remain subjects of ongoing debate. This review provides a brief overview of hypertension in frail older adults, especially for the management of BP in this population, which may help in offering valuable ideas for future research in this field.

Indexed as

Antihypertensive AgentsFrail ElderlyHypertensionAgedAged, 80 and overFrailtyHumansRisk FactorsAntihypertensive AgentsBlood pressureFrailtyHypertensionManagementOlder people

Identifiers

PMID39006023
PMCPMC11246622

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.